Detalhe da pesquisa
1.
Effect of 0.01% atropine combined with orthokeratology lens on axial elongation: a 2-year randomized, double-masked, placebo-controlled, cross-over trial.
Front Med (Lausanne);
11: 1358046, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38716420
2.
Development of a near-infrared single-photon 3D imaging LiDAR based on 64×64 InGaAs/InP array detector and Risley-prism scanner.
Opt Express;
32(5): 7426-7447, 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38439423
3.
Comparison of 0.02% atropine eye drops, peripheral myopia defocus design spectacle lenses, and orthokeratology for myopia control.
Clin Exp Optom;
: 1-7, 2023 Dec 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38043135
4.
Changes in axial length in anisometropic children wearing orthokeratology lenses.
Front Med (Lausanne);
10: 1266354, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38020088
5.
Prevention of myopia shift and myopia onset using 0.01% atropine in premyopic children - a prospective, randomized, double-masked, and crossover trial.
Eur J Pediatr;
182(6): 2597-2606, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36944782
6.
Effect of 0.02% and 0.01% atropine on ocular biometrics: A two-year clinical trial.
Front Pediatr;
11: 1095495, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36733432
7.
Combination of orthokeratology lens with 0.01% atropine in slowing axial elongation in children with myopia: a randomized double-blinded clinical trial.
BMC Ophthalmol;
22(1): 438, 2022 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36380280
8.
Effect of 0.02% and 0.01% atropine on astigmatism: a two-year clinical trial.
BMC Ophthalmol;
22(1): 161, 2022 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35392841
9.
Safety and efficacy of 0.02% and 0.01% atropine on controlling myopia progression: a 2-year clinical trial.
Sci Rep;
11(1): 22267, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34782708
10.
Risk factors for rapid axial length elongation with low concentration atropine for myopia control.
Sci Rep;
11(1): 11729, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34083576